获利能力 Profitability (单位:美元)
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | 30.18% | 133.78% | 150.18% | 76.35% | 63.63% | 48.92% | 84.57% | 101.16% |
| 总资产收益率(ROA) | 7.36% | 21.17% | 13.28% | 11.44% | 12.62% | 8.19% | 13.45% | 18.35% |
| 毛利率 | 78.22% | 78.85% | 77.66% | 74.18% | 76.77% | 79.25% | 81.31% | 83.04% |
| 净利率 | 15.04% | 37.27% | 25.24% | 19.71% | 21.88% | 15.36% | 23.51% | 31.67% |
| 每股收益(EPS) | 3.14 | 8.93 | 6.82 | 6.15 | 6.93 | 5.82 | 11.76 | 23.00 |
财务结构 Financial Structure
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 16.67% | 5.95% | 7.84% | 7.82% | 4.18% | 4.40% | 4.15% | 6.46% |
| 负债占总资产比率 | 75.15% | 93.13% | 87.51% | 81.24% | 78.23% | 83.03% | 81.87% | 76.41% |
经营能力 Operating Capability
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 4.68 | 4.91 | 4.18 | 4.24 | 4.14 | 3.75 | 4.09 | 3.67 |
| 平均收现日数 | 78 天 | 74 天 | 87 天 | 86 天 | 88 天 | 97 天 | 89 天 | 99 天 |
| 固定资产周转率(次) | 0.3720 | 0.3527 | 0.3538 | 0.3173 | 0.3554 | 0.3784 | 0.3797 | 0.3786 |
| 总资产周转率 | 48.95% | 56.81% | 52.62% | 58.02% | 57.67% | 53.31% | 57.22% | 57.95% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 73.21 | 23.38 | 36.57 | 38.18 | 20.67 | 28.19 | 32.68 | 72.68 |
| 净利润 | 32.32 | 83.18 | 61.94 | 55.82 | 62.45 | 52.40 | 105.90 | 206.40 |
| 经营活动现金流量 | 55.24 | 48.37 | 65.00 | 73.66 | 75.86 | 42.40 | 88.18 | 168.13 |
| 投资活动现金流量 | 19.06 | -80.83 | -22.59 | -28.68 | -37.63 | -71.53 | -93.02 | -109.72 |
| 筹资活动现金流量 | -59.05 | -23.24 | -31.37 | -41.31 | -54.07 | 34.96 | 12.30 | -22.13 |
| 净现金流量 | 14.62 | -56.61 | 13.20 | 1.61 | -17.52 | 7.52 | 4.49 | 40.00 |
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
25.81%
吉利德科学
GILD
28
24.45%
再生元制药
REGN
29
23.09%
德康医疗
DXCM
30
23.02%
瑞思迈
RMD